Sepsis-induced immunosuppression (SIS) is a common complication in patients with septic shock. Reduced expression of Human leukocyte antigen isotype DR (HLA-DR) on circulating monocytes is a marker for SIS and correlates with risk of secondary infections and mortality. The miRSep study aims to improve the understanding of early microRNA (miRNA) mediated changes in HLA-DR on monocytes in patients with septic shock.
Study Type
OBSERVATIONAL
Enrollment
56
Inselspital
Bern, Switzerland
RECRUITINGDifference in the miRNA-expression pattern in critically ill patients with/without sepsis-induced immunosuppression
Determine the early expression of specific miRNA candidates in monocytes of patients with sepsis induced immunosuppression compared to critically ill patients without sepsis induced immunosuppression using quantification by RT-qPCR
Time frame: 3 Days following ICU admission
Correlation between miRNA expression and sepsis outcome (30-day mortality)
Time frame: 30 days following ICU admission
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.